{"blog": [], "keywords": [{"value": "Alzheimer's Disease", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Clinical Trials", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "TauRx Pharmaceuticals Ltd", "name": "organizations", "rank": "4", "is_major": "Y"}], "web_url": "http://www.nytimes.com/2016/07/28/business/alzheimers-drug-lmtx-trial.html", "document_type": "article", "byline": {"person": [{"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 1}], "original": "By ANDREW POLLACK"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/07/28/business/28BRAIN/28BRAIN-thumbWide.jpg", "legacy": {"wide": "images/2016/07/28/business/28BRAIN/28BRAIN-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/07/28/business/28BRAIN/28BRAIN-articleLarge.jpg", "legacy": {"xlarge": "images/2016/07/28/business/28BRAIN/28BRAIN-articleLarge.jpg", "xlargeheight": "382", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 382}, {"url": "images/2016/07/28/business/28BRAIN/28BRAIN-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/07/28/business/28BRAIN/28BRAIN-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "1132", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "The drug did work on a handful of patients taking it alone, without another medication. But some experts were skeptical about the small subset.", "pub_date": "2016-07-27T12:01:54+0000", "news_desk": "Business", "headline": {"print_headline": "Alzheimer\u2019s Drug, Full of Promise, Falters in the Final Stage of Trials", "main": "Alzheimer\u2019s Drug LMTX Falters in Final Stage of Trials"}, "print_page": "9", "snippet": "The drug did work on a handful of patients taking it alone, without another medication. But some experts were skeptical about the small subset....", "_id": "5798a2b638f0d86000922a65", "slideshow_credits": null, "abstract": "New type of drug for Alzheimer's disease, called LMTX, fails to slow rate of decline in mental ability and daily functioning in its first large clinical trial; treatment, developed by TauRx Therapeutics, shows efficacy for fraction of patients, however. "}